Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

10 Commercial Trends To Watch In China in 2020

'4+N' Scheme And Immuno-Oncology Among Key Themes

Jan 10 2020

• By Brian Yang

Scrip Perspectives 2019 to 2020 — Trends To Watch In China In 2020

Related Content

Fifth PD-1, Zavicefta, Novel Psoriasis Ointment Among Latest China Approvals

Jun 04 2019

Access Pains After Approval In China? Consider The 'Three Ps'

Feb 08 2019

China's Akeso Bets On IO Antibody Combo With First US IND

May 03 2019

GSK Divests China Suzhou Site, Antiviral Rights To Fosun

Jul 12 2019

What’s At Stake As China Expands '4+7' Scheme: An Infographic Snapshot

Sep 19 2019

Catch It While You Can: Smaller Firms Flock To China As Value Takes Center Stage

Nov 25 2019

Ready To Ride Next Growth Wave In China? Remember Five Keys

Jun 20 2019

Asia Executives On The Move: BMS, Pfizer, Takeda, RDPAC

Dec 03 2019

Sun Allies With AZ To Drive China Oncology Push

Nov 07 2019

Second Spring? Coverage Expansion Fuels Big Pharma China Growth But '4+7' Impact Lingers

Oct 30 2019

What Lies Beneath China's Steep Price Cuts For New Drugs

Dec 05 2019

Related Companies

Merck & Co., Inc.

AstraZeneca PLC

Roche Holding AG

Sanofi

BeOne Medicines Ltd.

Pfizer Inc.

Jiangsu Hengrui Pharmaceuticals

Dr. Reddy's Laboratories Ltd.

Nichi-Iko Pharmaceutical Co., Ltd.

Sun Pharmaceutical Industries Ltd.

GSK plc

Eli Lilly and Company

Novartis AG

Bristol Myers Squibb Company

CStone Pharmaceuticals (Suzhou) Co., Ltd

Johnson & Johnson

Eisai Co., Ltd.

Additional Topics

China Asia Pacific Commercial Market Access Outlook 2020

More from China

More from Focus On Asia

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.